X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Pharmacogenomics & Personalized Medicine

期刊標題檢索 PHARMACOGEN PER 最新評論: The review process seems to be slow, but the editor accepted the revis... (2022-01-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Pharmacogenomics & Personalized Medicine]您好,您是該頁面的第 15094 位訪客。

期刊簡介
期刊名稱Pharmacogenomics & Personalized Medicine Pharmacogenomics & Personalized Medicine
LetPub Score
5.8
50 ratings
Rate

Reputation
7.1

Influence
4.7

Speed
7.0

期刊簡稱PHARMACOGEN PERS MED
ISSN1178-7066
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.300.5080.544
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q3199 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q3134 / 178

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling
Genetics and drug metabolism
Targeted drug identification and discovery
Optimizing drug selection & dosage based on patient's genetic profile
Drug related morbidity & mortality intervention
Advanced disease screening and targeted therapeutic intervention
Genetic based vaccine development
Patient satisfaction and preference
Health economic evaluations
Practical and organizational issues in the development and implementation of personalized medicine programs.
官方網站https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區New Zealand
發行頻率
創刊年0
每年文章數93每年文章數趨勢
黃金OA百分比98.46%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: genomic profiling、genetics、pharmacology、drug metabolism
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3240/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7066%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Pharmacogenomics & Personalized Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal for ImmunoTherapy of CancerH-index: 36

    CiteScore: 17.70
    Biomarker ResearchH-index: 0

    CiteScore: 15.80
    Cell Chemical BiologyH-index: 166

    CiteScore: 14.70
    Molecular BiomedicineH-index: 0

    CiteScore: 6.30
    Molecular OncologyH-index: 63

    CiteScore: 12.60
    VIROLOGICA SINICAH-index: 20

    CiteScore: 9.30
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 0

    CiteScore: 11.50
    Biotechnology JournalH-index: 70

    CiteScore: 8.90
    Frontiers in GeneticsH-index: 61

    CiteScore: 5.50
    Advances in Biological RegulationH-index: 0

    CiteScore: 8.90
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics332851
    Cell Chemical Biology78160
    Journal for ImmunoTherapy of Cancer76041
    Biotechnology Journal44109
    VIROLOGICA SINICA40948
    Biomarker Research37393
    Molecular Oncology31144
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE16366
    Molecular Biomedicine7009
    Exploration of Medicine4037
  •  

    Pharmacogenomics & Personalized Medicine Pharmacogenomics & Personalized Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Pharmacogenomics & Personalized Medicine] 的評論撰寫評論
作者: longda


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-01-05 20:50:52 評論於
The review process seems to be slow, but the editor accepted the revised version directly without giving any feedback to the reviewer.
(0) 讚! | longda

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Pharmacogenomics & Personalized Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*